Stonybrook Capital's Ravi Arps Promoted to Director

NEW YORK, NY -- (Marketwired) -- 09/28/15 --

Stonybrook Capital, a boutique investment and merchant banking firm focused on insurance, is pleased to announce the promotion of Ravi D. Arps to Director. Ravi is based in the firm’s New York office and works on transactions spanning various insurance sectors, but has recently focused on surety, property catastrophe, and professional liability.

Since joining Stonybrook as a founding member in 2012, Ravi has worked on over 100 transactions, specializing in valuation of complex entities, mergers and acquisitions under $100M in transaction value, and raising capital. Prior to joining Stonybrook, Ravi worked for Bridgewater Associates and Booz Allen Hamilton. He was Pre-Med and also holds a Bachelor of Science degree in Neuroscience from Wesleyan University.

"Ravi has been and continues to be a key member of our growing specialty team," states Joseph M. Scheerer, Founding Principal and Managing Director of Stonybrook. "I am pleased to recognize Ravi’s achievement, his creativity, and his tenacity in support of our clients."

Stonybrook Capital is a boutique investment and merchant banking firm focusing exclusively on the insurance industry, raising capital and advising on M&A for (re)insurance carriers, MGAs (and other fee-based entities), and private equity focused on the sector. The group is associated, through equity ownership, with HOLBORN Corporation -- a reinsurance intermediary based in New York City, which traces its roots back to 1920. Supported by a group of advisory board members composed of current and ex-industry executives, Stonybrook prides itself on providing the smartest possible service to its clients.

For more information on Stonybrook Capital, please see: www.stonybrookcapital.com

   JOSEPH M. SCHEERERSTONYBROOK CAPITALO (212) 412 9405M (917) 860 [email protected]

Source: Stonybrook Capital, LLC

You May Also Be Interested In

• American Crane & Equipment Corporation Joins United Way of Berks County for 10th Annual Big Cheese Milestone Event
• Phase II Trial of Cadonilimab(PD-1/CTLA-4) Combination Regimen Launches in the United States for Perioperative Treatment of Gastric Cancer
• New Anglia University: Why NHS Clinical Rotations Matter for Future Doctors